ECHELON
Report
- Report Number
- 2029214-2022-00220
- Event Type
- Injury
- Date Received
- February 14, 2022
- Date of Event
- December 6, 2020
- Report Date
- February 14, 2022
- Manufacturer
- MICRO THERAPEUTICS, INC. DBA EV3
- Product Code
- KRA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
UFLACKER A, HASKAL ZJ, PATRIE J, ET AL. IMPROVING CONE-BEAM CT ANGIOGRAPHY FOR PROSTATIC ARTERY EMBOLIZATION: IS A LOW-DOSE PROTOCOL EQUIVALENT TO THE STANDARD? JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2021;32(4):562-568. DOI:10.1016/J.JVIR.2020.12.016. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
UFLACKER A, HASKAL ZJ, PATRIE J, ET AL. IMPROVING CONE-BEAM CT ANGIOGRAPHY FOR PROSTATIC ARTERY EMBOLIZATION: IS A LOW-DOSE PROTOCOL EQUIVALENT TO THE STANDARD? JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2021;32(4):562-568. DOI:10.1016/J.JVIR.2020.12.016. MEDTRONIC LITERATURE REVIEW FOUND A REPORT OF PATIENT COMPLICATIONS IN ASSOCIATION WITH AN ECHELON MICROCATHETER. THE PURPOSE OF THIS ARTICLE WAS TO COMPARE THE UTILITY OF LOW-DOSE VERSUS STANDARD CONE-BEAM COMPUTED TOMOGRAPHY (CT) ANGIOGRAPHY PROTOCOLS IN IDENTIFYING NONTARGET EMBOLIZATION (NTE) DURING PROSTATIC ARTERY EMBOLIZATION (PAE). TWENTY-ONE PATIENTS WERE INCLUDED, AND THE MEAN AGE WAS 69.6 YEARS. THE ARTICLE DOES NOT STATE ANY TECHNICAL ISSUES DURING USE OF THE ECHELON MICROCATHETER. THE FOLLOWING INTRA- OR POST-PROCEDURAL OUTCOMES WERE NOTED: THERE WAS ONE MAJOR ADVERSE EVENT, WHICH WAS A CASE OF HYDRONEPHROSIS TREATED WITH URETERAL STENTS, WHICH RESOLVED WITHIN 3 MONTHS OF PLACEMENT. THIS MAJOR ADVERSE EVENT WAS DETERMINED TO BE LIKELY RELATED TO THE PROCEDURE, BUT NO OBVIOUS SOURCE OF NTE COULD BE IDENTIFIED IN THIS CASE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 585590 | ECHELON | CATHETER, CONTINUOUS FLUSH | KRA | MICRO THERAPEUTICS, INC. DBA EV3 | UNK-NV-ECHELON | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR | Male | Required Intervention |